Term ends Dec 18, 2032 · High confidence
20-year base term ends Aug 5, 2031
Held by AstraZeneca AB
Filed Aug 5, 2011 as application 13/198,764 · Granted Apr 28, 2015
Base term plus 501 days of patent term adjustment (USPTO delay)
Today
2011
2032
Clock starts
Aug 5, 2011
Aug 5, 2011
Term ends
Dec 18, 2032
Dec 18, 2032
Granted
Apr 28, 2015
Apr 28, 2015
base term
patent term adjustment
fee events
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
501
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
5
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 501 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Aug 5, 2011, when this application, 13/198,764, was filed | Aug 5, 2031 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +501 days, USPTO patent term adjustment record | Dec 18, 2032 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Dec 18, 2032 | High confidence |
This family
| US 9,018,381 | this patent Dec 2032 | Dec 2032 |
| Application 13/814,318 | Abandoned not computed | not computed |
| US 9,248,140 | In force Aug 2031 | Aug 2031 |
| Application 14/969,775 | Abandoned not computed | not computed |
4 of 5 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Oct 25, 2011 Reel 27114, frame 333 | Diebold, Robert Bruce; Gero, Thomas; Grover, Paul; Huang, Shan; Ioannidis, Stephanos; Ogoe, Claude Afona; Saeh, Jamal Carlos; Varnes, Jeffrey Gilbert | AstraZeneca AB | Assignment of Assignor's Interest |
| Oct 25, 2011 Reel 27114, frame 342 | AstraZeneca Pharmaceuticals LP | AstraZeneca AB | Assignment of Assignor's Interest |
| Dec 14, 2011 Reel 27380, frame 119 | Diebold, Robert Bruce; Gero, Thomas; Grover, Paul; Huang, Shan; Ioannidis, Stephanos; Ogoe, Claude Afona; Saeh, Jamal Carlos; Varnes, Jeffrey Gilbert | AstraZeneca Pharmaceuticals LP | Corrective Assignment to Correct the Assignee: Astrazeneca Ab Previously Recorded on Reel 027114 Frame 0333. Assignor(S) Hereby Confirms the Astrazeneca Pharmaceuticals LP. |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Dec 2032
Term ends Dec 18, 2032. No further fees fall due before then
Note
The 501 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
51
later US patents cite this one
That is top 10% of utility patents granted in 2015 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.